abrdn Life Sciences Investors - Common (HQL)

CUSIP: 87911K100

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common
Shares outstanding
29,948,325
Total 13F shares
2,171,425
Share change
-54,580
Total reported value
$40,653,000
Price per share
$18.73
Number of holders
41
Value change
-$924,995
Number of buys
20
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 87911K100?
CUSIP 87911K100 identifies HQL - abrdn Life Sciences Investors - Common in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of abrdn Life Sciences Investors - Common (HQL) as of Q3 2016

As of 30 Sep 2016, abrdn Life Sciences Investors - Common (HQL) was held by 41 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,171,425 shares. The largest 10 holders included MORGAN STANLEY, NEEDHAM INVESTMENT MANAGEMENT LLC, WELLS FARGO & COMPANY/MN, BANK OF NOVA SCOTIA, LPL Financial LLC, UBS Group AG, DOLIVER CAPITAL ADVISORS, INC., STIFEL FINANCIAL CORP, FIRST TRUST ADVISORS LP, and LADENBURG THALMANN FINANCIAL SERVICES INC. This page lists 41 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.